Advanced Renal Cell Carcinoma Treatment Market Size

Advanced Renal Cell Carcinoma Treatment Market size was over USD 6.71 billion in 2024 and is poised to exceed USD 13.96 billion by 2037, witnessing over 5.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of advanced renal cell carcinoma treatment is evaluated at USD 7.35 billion.

The growth of the market can be attributed to the increasing cases of renal cancer amongst the population across the globe. A family history of renal cancer is the biggest cause of the such type of cancer. For instance, renal cell carcinoma (RCC) is a dangerous neoplasm that accounts for around 5% of worldwide cancer diagnoses and fatalities, and its global burden is expected to radically rise in the coming years. Moreover, high blood pressure, along with excessive smoking, and the increasing awareness amongst the people regarding early diagnosis and treatment of cancer, is estimated to boost the global advanced renal cell carcinoma treatment market growth over the forecast period.

In addition to these, factors that are believed to fuel the market growth of advanced renal cell carcinoma treatment include the rise in inactive and sedentary lifestyles throughout the world. As per the World Health Organization (WHO) report, physical inactivity is responsible for around 2 million deaths worldwide each year. Sedentary lifestyles are practiced by 60 to 85% of people worldwide, including both developed and developing countries, making it one of the most severe yet under-addressed public health issues of the present time. In addition to this, a surge in the availability of novel drugs and treatments is the major factor that is projected to spur market growth during the forecast period.